Sponsor or institution

Clinical trials and research at Iovance Biotherapeutics, Inc.

• 6Clinical trials
• 16Countries

Newest trials

All recruiting trials (6)

• Lifileucel (Tumor-infiltrating lymphocytes) for advanced soft tissue sarcoma

  This study tests lifileucel, a cell therapy made from a patient’s own tumor cells, in adults with unresectable or metastatic soft tissue sarcoma who have had prior treatments to see if it helps shrink tumors and improve outcomes.

  Recruiting at 2 sites Phase 2 Iovance Biotherapeutics, Inc. · Tampa, Florida and 1 other locations · NCT07741877

• Investigating IOV-3001 for Advanced Melanoma Treatment

  This study is testing a new treatment called IOV-3001 to see if it can help adults with advanced melanoma who haven't been able to have surgery.

  Recruiting at 5 sites Phase 1/2 Iovance Biotherapeutics, Inc. · Denver, Colorado and 4 other locations · NCT06940739

• Using lifileucel to treat advanced endometrial cancer

  This study is testing if a new cell therapy called lifileucel can help adults with advanced endometrial cancer who haven't responded to other treatments.

  Recruiting at 12 sites Phase 2 Iovance Biotherapeutics, Inc. · Phoenix, Arizona and 11 other locations · NCT06481592

• Combining lifileucel with pembrolizumab for advanced melanoma treatment

  This study is testing if combining a new treatment called lifileucel with pembrolizumab can help people with advanced melanoma feel better compared to just using pembrolizumab alone.

  Recruiting at 71 sites Phase 3 Iovance Biotherapeutics, Inc. · Birmingham, Alabama and 81 other locations · NCT05727904

• Infusion of IOV-4001 for advanced melanoma and lung cancer

  This study is testing a new treatment called IOV-4001 to see if it can help adults with advanced melanoma and lung cancer by targeting and killing their tumor cells.

  Recruiting at 10 sites Phase 1/2 Iovance Biotherapeutics, Inc. · Los Angeles, California and 10 other locations · NCT05361174

• Using autologous LN-145 cell therapy for metastatic non-small-cell lung cancer

  This study is testing a new treatment using patients' own immune cells to see if it can help people with advanced non-small-cell lung cancer feel better.

  Recruiting at 65 sites Phase 2 Iovance Biotherapeutics, Inc. · Gilbert, Arizona and 70 other locations · NCT04614103

Quick answers

How many clinical trials run by Iovance Biotherapeutics, Inc. are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in United States (6 trials), Australia (3 trials), Canada (2 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →